IL97401A0 - Acetic acid derivatives,their preparation and pharmaceutical compositions containing them - Google Patents
Acetic acid derivatives,their preparation and pharmaceutical compositions containing themInfo
- Publication number
- IL97401A0 IL97401A0 IL97401A IL9740191A IL97401A0 IL 97401 A0 IL97401 A0 IL 97401A0 IL 97401 A IL97401 A IL 97401A IL 9740191 A IL9740191 A IL 9740191A IL 97401 A0 IL97401 A0 IL 97401A0
- Authority
- IL
- Israel
- Prior art keywords
- alkyl
- phenyl
- group
- conh
- coo
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
- C07C257/10—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
- C07C257/18—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to carbon atoms of six-membered aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/62—Compounds containing any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylcarbamates
- C07C271/64—Y being a hydrogen or a carbon atom, e.g. benzoylcarbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/75—Fibrinogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0205—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)3-C(=0)-, e.g. statine or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0207—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)4-C(=0), e.g. 'isosters', replacing two amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06104—Dipeptides with the first amino acid being acidic
- C07K5/06113—Asp- or Asn-amino acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
- C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0819—Tripeptides with the first amino acid being acidic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/1008—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Abstract
Acetic acid derivatives of formula H2N(NH)C-X-Y-CO-Z-CH(Q1)COOQ2 (I), their hydrates, solvates and salts. In (I), Q1 = H, CH3 or phenyl. Q2 = H, phenyl-alkyl or physiologically-cleavable alkyl. X = 1,4-phenylene, 2,5- or 3,6-pyridylene or 1,4-piperidylene, which is bound to Y via the 4-C atom. Y = -(CH2)n-CONH-CH(Q3)-(CH2)m- (where n = 0-2 and m = 1-3); -CONH-CH2-CH(Q4)-, -(CH2)2-NHCO-CH2-, -NHCO-(CH2)3-, or a group of formula (a), (b) or (c). In the formulae, Q3 = H, CH3, phenyl, COOH, -COO-alkyl, -CONH-(CH2)2-COOH or -CONH-(CH2)2-COO-alkyl. Q4 = H, CH3 or phenyl. Z = 1,4-piperazinyl, 1,4-piperidinyl (which is bound to the CO group via the 1-N atom) or a group of formula -NH-CH(R1)- or -NH-CH(COR2). R1 = H, CH3, phenyl or COO-alkyl. R2 = an alpha-amino carboxylic acid linked via the amino group (or its ester or amide) or a group of formula -NH-(CH2)2-Ar, -CO2R2, an optionally mono- or dialkylated -CONH2 group, or a pyrrolidinoyl or piperidinoyl. Ar = phenyl optionally substituted by alkyl, alkoxy, -COOH, -CO-alkyl, -O(CH2)p-COOH (p = 1-4), O(CH2)p-COO-alkyl, -CONH2, -CONH-alkyl, -CO(alkyl)2, pyrrolidinoyl or piperidinoyl.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH77590 | 1990-03-09 | ||
CH11591 | 1991-01-17 |
Publications (2)
Publication Number | Publication Date |
---|---|
IL97401A0 true IL97401A0 (en) | 1992-06-21 |
IL97401A IL97401A (en) | 1995-03-15 |
Family
ID=25683562
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL9740191A IL97401A (en) | 1990-03-09 | 1991-03-04 | Acetic acid derivatives, their preparation and pharmaceutical compositions containing them. |
Country Status (25)
Country | Link |
---|---|
EP (1) | EP0445796B1 (en) |
JP (1) | JP2501252B2 (en) |
KR (1) | KR910016765A (en) |
AT (1) | ATE167482T1 (en) |
BR (1) | BR9100941A (en) |
CA (1) | CA2037153A1 (en) |
DE (1) | DE59109010D1 (en) |
ES (1) | ES2118067T3 (en) |
FI (1) | FI911148A (en) |
HR (1) | HRP930353A2 (en) |
HU (1) | HUT56582A (en) |
IE (1) | IE910778A1 (en) |
IL (1) | IL97401A (en) |
IS (1) | IS3681A7 (en) |
MC (1) | MC2221A1 (en) |
MX (1) | MX24811A (en) |
MY (1) | MY105375A (en) |
NO (1) | NO301167B1 (en) |
NZ (1) | NZ237269A (en) |
PH (1) | PH30963A (en) |
PT (1) | PT96983B (en) |
RU (1) | RU2072359C1 (en) |
TW (1) | TW219928B (en) |
UY (1) | UY23197A1 (en) |
ZA (1) | ZA911534B (en) |
Families Citing this family (68)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5332726A (en) * | 1989-09-29 | 1994-07-26 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Antithrombotic peptides and pseudopeptides |
US5672585A (en) * | 1990-04-06 | 1997-09-30 | La Jolla Cancer Research Foundation | Method and composition for treating thrombosis |
US5780303A (en) * | 1990-04-06 | 1998-07-14 | La Jolla Cancer Research Foundation | Method and composition for treating thrombosis |
US6521594B1 (en) | 1990-04-06 | 2003-02-18 | La Jolla Cancer Research Foundation | Method and composition for treating thrombosis |
US6017877A (en) * | 1990-04-06 | 2000-01-25 | La Jolla Cancer Research Foundation | Method and composition for treating thrombosis |
US5545658A (en) * | 1991-03-26 | 1996-08-13 | Hoffman-La Roche Inc. | Amino acid derivatives |
RU2097378C1 (en) * | 1991-03-26 | 1997-11-27 | Ф.Хоффманн-Ля Рош Аг | DERIVATIVES OF N-ACYL-α-AMINO ACID OR THEIR PHYSIOLOGICALLY ACCEPTABLE SALTS, SIMPLE ETHERS OR ESTERS, AMIDES OR HYDRATES AND COMPOSITION INHIBITING ADHESIVE PROTEINS BINDING WITH PLATELETS AND PLATELET AGGREGATION |
EP0584066A4 (en) * | 1991-04-11 | 1994-10-12 | Rhone Poulenc Rorer Int | Anti-thrombotic peptide and pseudopeptide derivatives. |
ATE142641T1 (en) * | 1991-05-13 | 1996-09-15 | Fujisawa Pharmaceutical Co | NEW PEPTIDE COMPOUNDS AND METHODS FOR THE PRODUCTION THEREOF |
US5220050A (en) * | 1991-05-17 | 1993-06-15 | G. D. Searle & Co. | Peptide mimetic compounds useful as platelet aggregation inhibitors |
US5625093A (en) * | 1991-10-15 | 1997-04-29 | G. D. Searle & Co. | Substituted β-amino acid derivatives useful as platelet aggregation inhibitors |
US5239113A (en) * | 1991-10-15 | 1993-08-24 | Monsanto Company | Substituted β-amino acid derivatives useful as platelet aggregation inhibitors and intermediates thereof |
CA2115848A1 (en) * | 1991-10-15 | 1993-04-16 | Philippe Roger Bovy | Substituted heterocyclic derivatives useful as platelet aggregation inhibitors |
US5254573A (en) * | 1991-10-15 | 1993-10-19 | Monsanto Company | Substituted heterocyclic derivatives useful as platelet aggregation inhibitors |
WO1993012103A1 (en) * | 1991-12-13 | 1993-06-24 | G.D. Searle & Co. | Phenyl amidines lactones useful as platelet aggregation inhibitors |
US5424334A (en) * | 1991-12-19 | 1995-06-13 | G. D. Searle & Co. | Peptide mimetic compounds useful as platelet aggregation inhibitors |
US5227490A (en) * | 1992-02-21 | 1993-07-13 | Merck & Co., Inc. | Fibrinogen receptor antagonists |
WO1993018058A1 (en) * | 1992-03-06 | 1993-09-16 | G.D. Searle & Co. | Peptides mimics useful as platelet aggregation inhibitors |
HUT63609A (en) * | 1992-03-10 | 1993-09-28 | Sandoz Ag | Process for producing new derivatives and isosters of beta-amino acids and pharmaceutical compositions comprising such compounds |
AU4540693A (en) * | 1992-06-25 | 1994-01-24 | G.D. Searle & Co. | Phenyl amidine alkanoic acids and lactones useful as platelet aggregation inhibitors |
US5272162A (en) * | 1992-07-02 | 1993-12-21 | G. D. Searle & Co. | Platelet aggregation inhibitors |
US5354738A (en) * | 1992-09-04 | 1994-10-11 | G. D. Searle & Co. | Platelet aggregation inhibitors |
WO1994012181A1 (en) * | 1992-12-01 | 1994-06-09 | Merck & Co., Inc. | Fibrinogen receptor antagonists |
US5726192A (en) * | 1992-12-29 | 1998-03-10 | Smithkline Beecham Corporation | Platelet aggregation inhibiting compounds |
DE4301747A1 (en) * | 1993-01-23 | 1994-07-28 | Cassella Ag | Substituted amino compounds, their preparation and their use |
US5314902A (en) * | 1993-01-27 | 1994-05-24 | Monsanto Company | Urea derivatives useful as platelet aggregation inhibitors |
US5409939A (en) * | 1993-02-12 | 1995-04-25 | G. D. Searle & Co. | Phenyl amidine thio derivatives useful as platelet aggregation inhibitors |
US6268380B1 (en) * | 1993-02-19 | 2001-07-31 | G. D. Searle & Co. | Urea derivatives useful as platelet aggregation inhibitors |
WO1994020457A1 (en) * | 1993-03-02 | 1994-09-15 | G.D. Searle & Co. | N-acyl beta amino acid derivatives useful as platelet aggregation inhibitors |
US5652242A (en) * | 1993-03-29 | 1997-07-29 | Zeneca Limited | Heterocyclic derivatives |
GB9406144D0 (en) * | 1993-03-29 | 1994-05-18 | Zeneca Ltd | Heterocyclic compounds |
US5750754A (en) * | 1993-03-29 | 1998-05-12 | Zeneca Limited | Heterocyclic compounds |
US5753659A (en) * | 1993-03-29 | 1998-05-19 | Zeneca Limited | Heterocyclic compouds |
DK0691959T3 (en) * | 1993-03-29 | 1999-04-26 | Zeneca Ltd | Heterocyclic derivatives as platelet aggregation inhibitors |
US5612355A (en) * | 1993-06-23 | 1997-03-18 | G. D. Searle & Co. | Phenyl amidine lactones useful as platelet aggregation inhibitors |
US5463011A (en) * | 1993-06-28 | 1995-10-31 | Zeneca Limited | Acid derivatives |
GB9313285D0 (en) * | 1993-06-28 | 1993-08-11 | Zeneca Ltd | Acid derivatives |
GB9313268D0 (en) * | 1993-06-28 | 1993-08-11 | Zeneca Ltd | Chemical compounds |
US5430043A (en) * | 1993-08-24 | 1995-07-04 | G. D. Searle & Co. | Platelet aggregation inhibitors |
EP0669912B1 (en) * | 1993-09-22 | 2001-12-05 | Fujisawa Pharmaceutical Co., Ltd. | N-(3-piperidinylcarbonyl)-beta-alanine derivatives as paf antagonists |
US5780590A (en) * | 1993-10-15 | 1998-07-14 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides |
US5849736A (en) * | 1993-11-24 | 1998-12-15 | The Dupont Merck Pharmaceutical Company | Isoxazoline and isoxazole fibrinogen receptor antagonists |
US5446056A (en) * | 1993-11-24 | 1995-08-29 | The Du Pont Merck Pharmaceutical Company | Isoxazoline compounds useful as fibrinogen receptor antagonists |
US5523302A (en) * | 1993-11-24 | 1996-06-04 | The Du Pont Merck Pharmaceutical Company | Aromatic compounds containing basic and acidic termini useful as fibrinogen receptor antagonists |
US5563158A (en) * | 1993-12-28 | 1996-10-08 | The Dupont Merck Pharmaceutical Company | Aromatic compounds containing basic and acidic termini useful as fibrinogen receptor antagonists |
US5744485A (en) * | 1994-03-25 | 1998-04-28 | Vertex Pharmaceuticals Incorporated | Carbamates and ureas as modifiers of multi-drug resistance |
EP0790247A4 (en) * | 1994-11-01 | 2000-07-19 | Terumo Corp | Tetrahydroisoquinoline derivative and medicinal preparation containing the same |
US5795893A (en) * | 1994-12-22 | 1998-08-18 | Smithkline Beecham Corporation | Fibrinogen receptor antagonists |
JP3874455B2 (en) * | 1996-06-27 | 2007-01-31 | 新日本製鐵株式会社 | Fibrinogen receptor antagonist and pharmaceutical preparation containing the same as an active ingredient |
JP3874438B2 (en) * | 1994-12-28 | 2007-01-31 | 新日本製鐵株式会社 | Fibrinogen receptor antagonist having a substituted β-amino acid residue and pharmaceutical preparation containing the same as an active ingredient |
KR19980703107A (en) * | 1995-03-17 | 1998-10-15 | 후지야마 아키라 | N-acylpiperidinylcarbonylaminocarboxylic acid and glycoprotein IIB / IIa antagonists and their use as fibrinogen-platelet binding inhibitors |
US5811398A (en) * | 1995-04-11 | 1998-09-22 | G. D. Searle & Co. | Platelet aggregation inhibitors containing C-terminal aminergic side chain amino acid residues |
US5674894A (en) * | 1995-05-15 | 1997-10-07 | G.D. Searle & Co. | Amidine derivatives useful as platelet aggregation inhibitors and vasodilators |
ZA963391B (en) * | 1995-05-24 | 1997-10-29 | Du Pont Merck Pharma | Isoxazoline fibrinogen receptor antagonists. |
CZ293323B6 (en) * | 1995-08-30 | 2004-04-14 | G. D. Searle & Co. | Meta-guanidine, urea, thiourea or azacyclic amino benzoic acid derivatives as integrin antagonists |
PT892780E (en) * | 1996-02-22 | 2003-02-28 | Bristol Myers Squibb Pharma Co | M-AMIDINE PHENYL ANALOGS AS FACTOR XA INHIBITORS |
US5942544A (en) * | 1996-02-22 | 1999-08-24 | Dupont Pharmaceuticals Company | α-branched anilines, toluenes, and analogs thereof as factor Xa inhibitors |
EP0888302A1 (en) * | 1996-03-13 | 1999-01-07 | Fujisawa Pharmaceutical Co., Ltd. | N- (r)-1- 3-(4-piperidyl)propionyl-3-piperidylcarbonyl]-2(s)-acetylamino-beta-alanine as fibrinogen receptor antagonist |
US5872122A (en) * | 1997-10-16 | 1999-02-16 | Monsanto Company | Pyrimidinylamidino β-amino acid derivatives useful as inhibitors of platelet aggregation |
US6066651A (en) * | 1997-10-29 | 2000-05-23 | Ortho-Mcneil Pharmaceutical, Inc. | Orally-active nipecotamide glycolamide esters for the treatment of thrombosis disorders |
US6100282A (en) | 1998-01-02 | 2000-08-08 | Hoffman-La Roche Inc. | Thiazole derivatives |
SI0928790T1 (en) * | 1998-01-02 | 2003-06-30 | F. Hoffmann-La Roche Ag | Thiazole derivatives |
US6037365A (en) * | 1998-09-25 | 2000-03-14 | G.D. Searle & Co. | Aminobenzamidinosuccinyl lactone derivatives useful as inhibitors of platelet aggregation |
CZ20011395A3 (en) | 1998-10-22 | 2001-08-15 | F. Hoffmann-La Roche Ag | Thiazole derivatives |
IL143901A0 (en) | 1998-12-23 | 2002-04-21 | Searle & Co | Use of cyclooxygenase-2- inhibitor, a matrix metallaproteinase inhibitor, an antineoplastic agent and optionally radiation as a combination treatment of neoplasia |
GB0019008D0 (en) * | 2000-08-04 | 2000-09-27 | Astrazeneca Ab | Therapeutic compounds |
EP1193248A1 (en) * | 2000-09-30 | 2002-04-03 | Aventis Pharma Deutschland GmbH | Malonamid and malonamic ester derivatives with antithrombotic activity, their preparation and their use |
US7317019B2 (en) | 2003-08-21 | 2008-01-08 | Bristol Myers Squibb Co. | N-alkylated diaminopropane derivatives as modulators of chemokine receptor activity |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0183271B1 (en) * | 1984-11-30 | 1990-05-16 | Shosuke Okamoto | Lysin derivative and proteinase inhibitor |
-
1991
- 1991-02-26 CA CA002037153A patent/CA2037153A1/en not_active Abandoned
- 1991-02-27 TW TW080101540A patent/TW219928B/zh active
- 1991-03-01 NZ NZ237269A patent/NZ237269A/en unknown
- 1991-03-01 ZA ZA911534A patent/ZA911534B/en unknown
- 1991-03-04 HU HU91186A patent/HUT56582A/en unknown
- 1991-03-04 IL IL9740191A patent/IL97401A/en not_active IP Right Cessation
- 1991-03-06 MC MC912175A patent/MC2221A1/en unknown
- 1991-03-07 AT AT91103462T patent/ATE167482T1/en not_active IP Right Cessation
- 1991-03-07 RU SU914894657A patent/RU2072359C1/en active
- 1991-03-07 EP EP91103462A patent/EP0445796B1/en not_active Expired - Lifetime
- 1991-03-07 DE DE59109010T patent/DE59109010D1/en not_active Expired - Fee Related
- 1991-03-07 MX MX2481191A patent/MX24811A/en unknown
- 1991-03-07 ES ES91103462T patent/ES2118067T3/en not_active Expired - Lifetime
- 1991-03-07 MY MYPI91000363A patent/MY105375A/en unknown
- 1991-03-07 FI FI911148A patent/FI911148A/en unknown
- 1991-03-07 JP JP3065316A patent/JP2501252B2/en not_active Expired - Lifetime
- 1991-03-08 PT PT96983A patent/PT96983B/en not_active IP Right Cessation
- 1991-03-08 KR KR1019910003736A patent/KR910016765A/en not_active Application Discontinuation
- 1991-03-08 IS IS3681A patent/IS3681A7/en unknown
- 1991-03-08 IE IE077891A patent/IE910778A1/en unknown
- 1991-03-08 BR BR919100941A patent/BR9100941A/en not_active Application Discontinuation
- 1991-03-08 UY UY23197A patent/UY23197A1/en not_active IP Right Cessation
- 1991-03-08 NO NO910934A patent/NO301167B1/en unknown
- 1991-03-08 PH PH42106A patent/PH30963A/en unknown
-
1993
- 1993-03-12 HR HR930353A patent/HRP930353A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
JPH04217652A (en) | 1992-08-07 |
NZ237269A (en) | 1993-05-26 |
PT96983B (en) | 1998-07-31 |
TW219928B (en) | 1994-02-01 |
HUT56582A (en) | 1991-09-30 |
JP2501252B2 (en) | 1996-05-29 |
EP0445796A3 (en) | 1991-10-30 |
ZA911534B (en) | 1991-11-27 |
EP0445796A2 (en) | 1991-09-11 |
NO910934D0 (en) | 1991-03-08 |
CA2037153A1 (en) | 1991-09-10 |
ES2118067T3 (en) | 1998-09-16 |
MX24811A (en) | 1993-11-01 |
FI911148A0 (en) | 1991-03-07 |
MC2221A1 (en) | 1993-02-02 |
ATE167482T1 (en) | 1998-07-15 |
MY105375A (en) | 1994-09-30 |
FI911148A (en) | 1991-09-10 |
RU2072359C1 (en) | 1997-01-27 |
BR9100941A (en) | 1991-11-05 |
NO910934L (en) | 1991-09-10 |
IL97401A (en) | 1995-03-15 |
KR910016765A (en) | 1991-11-05 |
PH30963A (en) | 1997-12-23 |
UY23197A1 (en) | 1991-09-04 |
DE59109010D1 (en) | 1998-07-23 |
EP0445796B1 (en) | 1998-06-17 |
IE910778A1 (en) | 1991-09-11 |
HRP930353A2 (en) | 1996-06-30 |
HU910186D0 (en) | 1991-08-28 |
IS3681A7 (en) | 1991-09-10 |
NO301167B1 (en) | 1997-09-22 |
PT96983A (en) | 1991-10-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL97401A0 (en) | Acetic acid derivatives,their preparation and pharmaceutical compositions containing them | |
DK0412404T3 (en) | Thiazole derivatives, processes for their preparation and pharmaceutical compositions comprising the derivatives | |
DK0641759T3 (en) | Use of aromatic carboxylic acid derivatives for the preparation of pharmaceutical compositions | |
NO304375B1 (en) | New 2-saccharinylmethylaryl carboxylates useful as inhibitors of proteolytic enzymes, preparations and use thereof | |
DK0841330T3 (en) | Heterocyclic aminomethyl derivatives, process for their preparation and pharmaceutical compositions containing the derivatives | |
KR0165901B1 (en) | 4-[(2-BENZOTHIAZOLYL) METHYLAMINO]-Ñß-[(3,4-DIFLUOROPHENOXY)METHYL]-1-PIPERIDINE ETHANOL | |
DK1010693T3 (en) | Novel imidazoline compounds, processes for their preparation and pharmaceutical compositions containing them | |
DK0864561T3 (en) | Benzenesulfonylamine derivatives, process for their preparation and pharmaceutical compositions containing such derivatives | |
HUP9702315A2 (en) | 4-hydroxy-piperidine derivatives, preparation and use thereof, pharmaceutical compositions containing these compounds | |
IL150419A0 (en) | Carboxamide diazepin derivatives, preparation method, use as medicines, pharmaceutical compositions and use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
KB | Patent renewed | ||
MM9K | Patent not in force due to non-payment of renewal fees |